Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 2947,"Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.",blood insulin amount,,RS:0001827,Crl:LE,male,91 days,5,,CMO:0000349,blood insulin level,,,,29.1,mU/l,4.6957,10.5,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition (for 91 days),104305,control condition (for 91 days), 2947,"Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013.",blood insulin amount,,RS:0003393,LE-Lrrk2em1Sage-/-,male,91 days,5,,CMO:0000349,blood insulin level,,,,55.5,mU/l,13.1928,29.5,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition (for 91 days),104306,control condition (for 91 days), 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",blood insulin amount,,RS:0001011,Crl:WI,male,147 days,6,,CMO:0000349,blood insulin level,,,,77.64768,mU/l,21.7649,53.3129,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition,103996,control condition, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",blood insulin amount,,RS:0001011,Crl:WI,male,147 days,6,,CMO:0000349,blood insulin level,,,,82.94184,mU/l,19.706,48.2697,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),103998,control condition,controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",blood insulin amount,,RS:0001317,GK/MolTac,male,147 days,6,,CMO:0000349,blood insulin level,,,,57.64752,mU/l,11.4707,28.0973,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition,103999,control condition, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",blood insulin amount,,RS:0001317,GK/MolTac,male,147 days,12,,CMO:0000349,blood insulin level,,,,65.29464,mU/l,8.8236,30.5658,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition,104001,control condition, 2885,"Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170.",blood insulin amount,,RS:0001317,GK/MolTac,male,147 days,12,,CMO:0000349,blood insulin level,,,,71.47116,mU/l,8.2354,28.5281,MMO:0000320,blood insulin analysis,,0.0,,,,,control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days),104003,control condition,controlled saxagliptin content diet (10 mg/kg/d) (for 12 days)